SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062822-17-000028
Filing Date
2017-04-27
Accepted
2017-04-27 16:15:53
Documents
4
Period of Report
2017-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K (2017 ANNUAL MEETING) form8-kxannualmeeting04x27.htm 8-K 61232
2 2017 EQUITY INCENTIVE PLAN exhibit101-2017equityincen.htm EX-10.1 112533
3 2017 NON-EMPLOYEE DIRECTORS EQUITY INCENTIVE PLAN exhibit102-2017nonxemploye.htm EX-10.2 76700
4 NON-EMPLOYEE DIRECTOR COMPENSATION exhibit103-summaryofnonxem.htm EX-10.3 7097
  Complete submission text file 0001062822-17-000028.txt   258959
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 17789265
SIC: 2834 Pharmaceutical Preparations